Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

MC964

Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases/96 cores, replacing MC961
Unstained: $255.00 Add to Cart
H&E (MC964s*): $255.00 Add to Cart

Microarray Panel:Multiple organ tumor tissue microarray, 33 types of cancer (brain, esophagus, stomach, liver, small intestine, colon, rectum, pancreas, epiploon, lung, cervix, uterus, breast, ovary, spleen, prostate, testis, kidney, bladder, lymph node, mediastinum, mesentery, bone, cheek, tongue, nose, larynx, pharynx, lip, fatty tissue, fibrous tissue, thyroid, skin) single core per case
Cores:96
Cases:96
Layout:12 cols × 8 rows
Core Diameter:1 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
123456789101112 
A Cer Cer Cer Cer Cer Cer Eso Eso Eso Sto Sto Sto  
B Liv Liv Liv Sma Sma Sma Col Col Col Rec Rec Rec  
C Pan Pan Pan Gre Gre Gre Lun Lun Lun Lun Lun Lun  
D Ute Ute Ute Ute Ute Ute Bre Bre Bre Ova Ova Ova  
E Spl Spl Spl Pro Pro Pro Tes Tes Tes Kid Kid Kid  
F Bla Bla Bla Lym Lym Lym Lym Med Mes Bon Bon Bon  
G Bon Bon Bon Che Lip Nos Pha Lar Lar Pha Lar Nas  
H Ton Ton Ton Fat Fib Fib Thr Thr Thr Ski Ski Ski Marked point
Legend: Bla - Bladder, Bon - Bone, Bre - Breast, Cer - Cerebrum, Che - Cheek, Col - Colon, Eso - Esophagus, Fat - Fatty tissue, Fib - Fibrous tissue, Gre - Greater omentum, Kid - Kidney, Lar - Larynx, Lip - Lip, Liv - Liver, Lun - Lung, Lym - Lymph node, Med - Mediastinum, Mes - Mesentery, Nas - Nasopharynx, Nos - Nose, Ova - Ovary, Pan - Pancreas, Pha - Pharynx, Pro - Prostate, Rec - Rectum, Ski - Skin, Sma - Small intestine, Spl - Spleen, Sto - Stomach, Tes - Testis, Thr - Thyroid, Ton - Tongue, Ute - Uterus

- Malignant tumor, - Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage III), - Malignant tumor (stage IIIa), - Malignant tumor (stage IIIb), - Malignant tumor (stage IIa), - Malignant tumor (stage IIb), - Malignant tumor (stage IV), - Malignant tumor (stage Ia), - Malignant tumor (stage Ib), - Malignant tumor (stage Ic), - Malignant tumor (stage Iib), - Metastasis

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 M 39 Cerebrum Astrocytoma of brain 1 – – Malignant
A2 2 M 55 Cerebrum Anaplastic oligodendroglioma of brain – – – Malignant
A3 3 M 2 Cerebrum Malignant ependymoma of brain – – – Malignant
A4 4 F 36 Cerebrum Astrocytoma of brain 2 – – Malignant
A5 5 M 43 Cerebrum Astrocytoma of brain 3 – – Malignant
A6 6 F 10 Cerebrum Glioblastoma of brain – – – Malignant
A7 7 M 63 Esophagus Squamous cell carcinoma of esophagus 3 IIa T2N0M0 Malignant
A8 8 M 64 Esophagus Squamous cell carcinoma of esophagus 3 IIa TT2N0M0 Malignant
A9 9 M 67 Esophagus Squamous cell carcinoma of esophagus 3 IIa T3N0M0 Malignant
A10 10 M 59 Stomach Adenocarcinoma of stomach 2 II T3N0M0 Malignant
A11 11 F 61 Stomach Adenocarcinoma of stomach 3 II T3N0M0 Malignant
A12 12 F 69 Stomach Interstitialoma of stomach – IIa T2N0M0 Malignant
B1 13 M 56 Liver Hepatocellular carcinoma of liver 2 III T3N0M0 Malignant
B2 14 M 32 Liver Cholangioma of liver 2 III T3N0M0 Malignant
B3 15 F 17 Liver Hepatoblastoma of liver – – – Malignant
B4 16 F 70 Small intestine Adenocarcinoma of small intestine 3 II T3N0M0 Malignant
B5 17 F 52 Small intestine Diffuse B-cell lymphoma of small intestine – – – Malignant
B6 18 F 36 Small intestine Interstitialoma of small intestine – IIa T2N0M0 Malignant
B7 19 M 46 Colon Adenocarcinoma of colon 3 II T4N0M0 Malignant
B8 20 M 61 Colon Interstitialoma of colon – IIIb T2N0M0 Malignant
B9 21 M 55 Colon Diffuse B-cell lymphoma of colon – – – Malignant
B10 22 F 47 Rectum Adenocarcinoma of rectum 2 II T4N0M0 Malignant
B11 23 M 63 Rectum Interstitialoma of rectum – Ib T2N0M0 Malignant
B12 24 M 57 Rectum Interstitialoma of rectum – Iib T2N0M0 Malignant
C1 25 F 15 Pancreas Islet cell carcinoma of pancreas – – Malignant
C2 26 F 57 Pancreas Adenocarcinoma of pancreas 3 I T2N0M0 Malignant
C3 27 M 64 Pancreas Adenocarcinoma (sparse) of pancreas 2 II T3N0M0 Malignant
C4 28 F 38 Greater omentum Metastatic adenocarcinoma of greater omentum 3 – – Metastasis
C5 29 F 26 Greater omentum Metastatic dysgerminoma of greater omentum – – – Metastasis
C6 30 F 70 Greater omentum Interstitialoma of greater omentum – Ib T2N0M0 Malignant
C7 31 M 50 Lung Small cell undifferentiated carcinoma of lung – I T2N0M0 Malignant
C8 32 F 48 Lung Small cell undifferentiated carcinoma of lung – I T2N0M0 Malignant
C9 33 M 59 Lung Atypical carcinoid of lung – I T2N0M0 Malignant
C10 34 F 39 Lung Squamous cell carcinoma of lung 2 II T2N1M0 Malignant
C11 35 F 58 Lung Adenocarcinoma of lung 2 II T2N1M0 Malignant
C12 36 M 62 Lung Squamous cell carcinoma of lung 3 IIIa T3N0M0 Malignant
D1 37 F 57 Uterine cervix Squamous cell carcinoma of cervix 2 I T1N0M0 Malignant
D2 38 F 42 Uterine cervix Squamous cell carcinoma (sparse) of cervix – Ia T1N0M0 Malignant
D3 39 F 49 Uterine cervix Squamous cell carcinoma of cervix 3 – – Malignant
D4 40 F 66 Uterus Endometrial adenocarcinoma of uterus 3 Ic T1cN0M0 Malignant
D5 41 F 21 Uterus Endometrial stromal sarcoma (smooth muscle) of uterus – Ib T2N0M0 Malignant
D6 42 F 70 Uterus Clear cell carcinoma of uterus – Ib T1bN0M0 Malignant
D7 43 F 49 Breast Invasive lobular carcinoma of breast – IIIb T4N1M0 Malignant
D8 44 F 40 Breast Invaisve ductal carcinoma of breast 2 IIb T3N0M0 Malignant
D9 45 F 40 Breast Cystosarcoma phyllodes of breast – Ib T2N0M0 Malignant
D10 46 F 60 Ovary Serous adenocarcinoma (necrotic tissue) of ovary – I T1N0M0 Malignant
D11 47 F 40 Ovary Serous adenocarcinoma of ovary 3 I T1N0M0 Malignant
D12 48 F 57 Ovary Serous adenocarcinoma of ovary 3 III T3N0M0 Malignant
E1 49 M 47 Spleen Diffuse B-cell lymphoma of spleen – – – Malignant
E2 50 M 39 Spleen Diffuse non-Hodgkin's lymphoma of spleen – – – Malignant
E3 51 M 77 Spleen Diffuse B-cell lymphoma of spleen – – – Malignant
E4 52 M 74 Prostate Adenocarcinoma of prostate 1 IV T4N1M1c Malignant
E5 53 M 81 Prostate Transitional cell carcinoma of prostate 3 III T4N0M0 Malignant
E6 54 M 79 Prostate Transitional cell carcinoma of prostate 3 II T2N0M0 Malignant
E7 55 M 52 Testis Seminoma of testis – I T2N0M0 Malignant
E8 56 M 76 Testis Diffuse B-cell lymphoma of testis – – – Malignant
E9 57 M 43 Testis Embryonal carcinoma of testis – I T2N0M0 Malignant
E10 58 F 61 Kidney Clear cell carcinoma of kidney 1 I T1N0M0 Malignant
E11 59 M 76 Kidney Clear cell carcinoma of kidney 1 IV T4N0M0 Malignant
E12 60 M 37 Kidney Sarcomatoid carcinoma of kidney – I T1N0M0 Malignant
F1 61 M 75 Bladder Transitional cell carcinoma of bladder 3 II T2N0M0 Malignant
F2 62 M 32 Bladder Mucinous adenocarcinoma of bladder 2–3 II T2N0M0 Malignant
F3 63 M 62 Bladder Leiomyosarcoma of bladder – Ib T2N0M0 Malignant
F4 64 F 42 Lymph node Hodgkin's lymphoma of neck – – – Malignant
F5 65 M 41 Lymph node Hodgkin's lymphoma of neck – – – Malignant
F6 66 M 43 Lymph node Diffuse B-cell lymphoma of left groin – – – Malignant
F7 67 M 15 Lymph node Diffuse B-cell lymphoma of right elbow joint – – – Malignant
F8 68 M 39 Mediastinum Diffuse T-cell lymphoma of mediastinum – – – Malignant
F9 69 M 53 Mesentery Diffuse B-cell lymphoma of mesentery – – – Malignant
F10 70 F 40 Bone Osteosarcoma of left leg – IIb T2N0M0 Malignant
F11 71 M 19 Bone Osteosarcoma of right femur – Ia T1N0M0 Malignant
F12 72 F 14 Bone Osteosarcoma of right femur – Ia T1N0M0 Malignant
G1 73 M 50 Bone Chondrosarcoma of rib – – – Malignant
G2 74 M 14 Bone Chondrosarcoma of right femur – – – Malignant
G3 75 M 47 Bone Mesenchymal chondrosarcoma of pars sacralis – – – Malignant
G4 76 F 51 Cheek Squamous cell carcinoma of cheek 1 IV T4N0M0 Malignant
G5 77 M 74 Lip Squamous cell carcinoma of lip 1 I T1N0M0 Malignant
G6 78 M 63 Nose Squamous cell carcinoma of nose 1 I T1N0M0 Malignant
G7 79 M 62 Pharynx Squamous cell carcinoma of pharynx 1 I T1N0M0 Malignant
G8 80 M 52 Larynx Squamous cell carcinoma (sparse) of larynx 1 III T3N0M0 Malignant
G9 81 M 47 Larynx Squamous cell carcinoma of larynx 3 II T2N0M0 Malignant
G10 82 M 60 Pharynx Diffuse B-cell malignant lymphoma of pharynx – – – Malignant
G11 83 M 58 Larynx Squamous cell carcinoma of larynx 1 III T3N0M0 Malignant
G12 84 M 62 Nasopharynx Squamous cell carcinoma of nasopharynx 3 I T1N0M0 Malignant
H1 85 M 57 Tongue Squamous cell carcinoma of tongue 1 I T1N0M0 Malignant
H2 86 M 18 Tongue Embryonal rhabdomyosarcoma of tongue – IIIa T1bN0M0 Malignant
H3 87 M 50 Tongue Mucoepidermoid carcinoma of tongue – I T1N0M0 Malignant
H4 88 M 47 Fatty tissue Mucoid liposarcoma of left leg – IIa T1N0M0 Malignant
H5 89 M 41 Fibrous tissue Isolated fibroma of chest wall – Ib T2N0M0 Malignant
H6 90 M 45 Fibrous tissue Fibrosarcoma of left forearm – IIb T2N0M0 Malignant
H7 91 F 52 Thyroid Medullary carcinoma of thyroid – II T3N0M0 Malignant
H8 92 M 21 Thyroid Papillary carcinoma of thyroid – I T2N0M0 Malignant
H9 93 F 62 Thyroid Diffuse B-cell lymphoma of thyroid – – – Malignant
H10 94 M 45 Skin Malignant melanoma of anus margin – II T4N0M0 Malignant
H11 95 M 57 Skin Basal cell carcinoma of scalp – I T2N0M0 Malignant
H12 96 M 46 Skin Squamous cell carcinoma of left chest wall 2 II T3N0M0 Malignant
– – M 58 Skin Malignant melanoma (tissue marker) – Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal